Logo image of OMDA

OMADA HEALTH INC (OMDA) Stock Fundamental Analysis

NASDAQ:OMDA - US68170A1088 - Common Stock

23.5 USD
-0.65 (-2.69%)
Last: 9/9/2025, 8:00:02 PM
23.3 USD
-0.2 (-0.85%)
After Hours: 9/9/2025, 8:00:02 PM
Fundamental Rating

3

OMDA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While OMDA seems to be doing ok healthwise, there are quite some concerns on its profitability. OMDA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OMDA had negative earnings in the past year.
OMDA Yearly Net Income VS EBIT VS OCF VS FCFOMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

OMDA has a worse Return On Assets (-15.56%) than 79.21% of its industry peers.
Looking at the Return On Equity, with a value of -22.00%, OMDA is doing worse than 66.34% of the companies in the same industry.
Industry RankSector Rank
ROA -15.56%
ROE -22%
ROIC N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMDA Yearly ROA, ROE, ROICOMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60

1.3 Margins

With an excellent Gross Margin value of 60.59%, OMDA belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
OMDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMDA Yearly Profit, Operating, Gross MarginsOMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

OMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OMDA has about the same amount of shares outstanding.
Compared to 1 year ago, OMDA has a worse debt to assets ratio.
OMDA Yearly Shares OutstandingOMDA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
OMDA Yearly Total Debt VS Total AssetsOMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

OMDA has an Altman-Z score of 7.95. This indicates that OMDA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.95, OMDA belongs to the top of the industry, outperforming 92.08% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that OMDA is not too dependend on debt financing.
OMDA's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. OMDA outperforms 72.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 7.95
ROIC/WACCN/A
WACC8.72%
OMDA Yearly LT Debt VS Equity VS FCFOMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

OMDA has a Current Ratio of 4.68. This indicates that OMDA is financially healthy and has no problem in meeting its short term obligations.
OMDA has a better Current ratio (4.68) than 92.08% of its industry peers.
A Quick Ratio of 4.62 indicates that OMDA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.62, OMDA belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.68
Quick Ratio 4.62
OMDA Yearly Current Assets VS Current LiabilitesOMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.18% over the past year.
OMDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.29%.
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 32.87% on average over the next years. This is a very strong growth
OMDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.41% yearly.
EPS Next Y62.06%
EPS Next 2Y39.57%
EPS Next 3Y32.87%
EPS Next 5YN/A
Revenue Next Year43.43%
Revenue Next 2Y31.2%
Revenue Next 3Y27.41%
Revenue Next 5YN/A

3.3 Evolution

OMDA Yearly Revenue VS EstimatesOMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
OMDA Yearly EPS VS EstimatesOMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.2 -0.2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OMDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OMDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OMDA Price Earnings VS Forward Price EarningsOMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMDA Per share dataOMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

OMDA's earnings are expected to grow with 32.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.57%
EPS Next 3Y32.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OMDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OMADA HEALTH INC

NASDAQ:OMDA (9/9/2025, 8:00:02 PM)

After market: 23.3 -0.2 (-0.85%)

23.5

-0.65 (-2.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)N/A N/A
Inst Owners46.34%
Inst Owner ChangeN/A
Ins Owners6.09%
Ins Owner Change100%
Market Cap1.35B
Analysts81.43
Price Target28.27 (20.3%)
Short Float %3.26%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.12%
PT rev (3m)N/A
EPS NQ rev (1m)31.75%
EPS NQ rev (3m)N/A
EPS NY rev (1m)44.66%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)10.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)7.63%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.97
P/FCF N/A
P/OCF N/A
P/B 6.32
P/tB 6.84
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.95
BVpS3.72
TBVpS3.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.56%
ROE -22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.59%
FCFM N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.68
Quick Ratio 4.62
Altman-Z 7.95
F-ScoreN/A
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)69.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y62.06%
EPS Next 2Y39.57%
EPS Next 3Y32.87%
EPS Next 5YN/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year43.43%
Revenue Next 2Y31.2%
Revenue Next 3Y27.41%
Revenue Next 5YN/A
EBIT growth 1Y33.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.57%
EBIT Next 3Y30.02%
EBIT Next 5YN/A
FCF growth 1Y27.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.28%
OCF growth 3YN/A
OCF growth 5YN/A